Is Gland Pharma Ltd. (GLAND) Halal?

Gland Pharma Ltd. (GLAND) is evaluated as Not Halal (Non-compliant) under the AAOIFI standard. Reasons: Impure Revenue: Non-permissible income 3.21% exceeds limit 3.0%.

What is the dividend purification rate for GLAND?

The non-permissible dividend purification factor for Gland Pharma Ltd. is 3.21%.

Back to Search

GLAND

NSEHealthcareCap: ₹51085.71 Cr

Gland Pharma Ltd.

+81.87%YTD

AAOIFI MSCI DJIM BSE_TASIS

Non-Compliant (Not Permissible)

Evaluated using BSE_TASIS criteria

Reasons for Non-Compliance:

Impure Revenue: Non-permissible income 3.21% exceeds limit 3.0%.

Market Fundamentals

Live NSE/BSE

Market Cap

₹51085.71 Cr

P/E Ratio

45.2x

P/B Ratio

4.9x

52W High

₹3,171

52W Low

₹1,573.6

Div. Yield

65.00%

Shares O/S

16.50 Cr

Where Does the Money Come From?

Revenue breakdown for Gland Pharma Ltd.

Core Healthcare OperationsPermissible Operating Activity

Permissible: Core operations in Healthcare.

96.8%of Total Revenue

Treasury Interest & Secondary Non-Operating IncomeImpure Interest Income (Riba)

Non-operating interest income earned from cash and fixed deposits. Requires purification.

3.2%of Total Revenue

About Gland Pharma Ltd.

Permissible: Core operations in Healthcare.

Interest-Bearing Debt Ratio

2.27%Max: ≤ 33.0%

Cash & Securities Liquidity

27.44%Max: ≤ 33.0%

Impure Revenue Ratio

3.21%Max: ≤ 5.0%

Screening Denominator

Total Assets

Halal Alternatives in Healthcare

Can't invest in GLAND? Consider these instead

BSE_TASIS Verified

ACUTAAS

Acutaas Chemicals Ltd.

HalalPurification: 0.64%

GRANULES

Granules India Ltd.

HalalPurification: 0.13%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

HalalPurification: 1.57%

Purification & Zakat Calculator

Calculate how much to donate for GLAND

⚠️ Note: GLAND is not Halal. The right step is to sell this stock, not just purify the dividends. Keeping a non-compliant investment is not resolved by Sadaqah.